News

‘Deal with the Devil’: Harvard Medical School Faculty Grapple with Increased Industry Research Funding

News

As Dean Long’s Departure Looms, Harvard President Garber To Appoint Interim HGSE Dean

News

Harvard Students Rally in Solidarity with Pro-Palestine MIT Encampment Amid National Campus Turmoil

News

Attorneys Present Closing Arguments in Wrongful Death Trial Against CAMHS Employee

News

Harvard President Garber Declines To Rule Out Police Response To Campus Protests

Arts Concentration Will Not Hurt Medical School Admission--Leighton

NO WRITER ATTRIBUTED

"Don't let anyone say that you cannot concentrate in a non-scientific field and still be admitted to medical school," Delmare Leighton '19, Dean of Students, said last night.

Speaking before the vocational conference on medical and dental sciences in Winthrop House. Leighton cited newly-prepared statistics relating undergraduate fields of concentration to medical school admissions.

Of the members of the College Class of '52 who applied to medical school, said Leighton, 86 per cent of those who had been pre-med majors were accepted, as compared to '74, percent of those who had concentrated in the 16 non-scientific fields.

Divided Class

Dividing the Class of '52 into its upper and lower academic halves, Leighton emphasized that of those in the bottom half who majored in non-scientific fields and applied to medical schools, fully 48 percent were still accepted.

Of the pre-med students in the top half of the Class of '52, who majored in scientific fields, however, 96 percent were admitted to medical schools, he said.

The "big four" medical schools for graduates of the College, according to Leighton, are Harvard, Tufts, Boston University, and Columbia, in that order. In a recent four-year period, over half of the College's medicine-bound graduates went to these four schools.

Another speaker at the conference was Dana. L. Farnsworth, Medical Director of M.I.T., who spoke on "Opportunities in Psychiatry."

Want to keep up with breaking news? Subscribe to our email newsletter.

Tags